Question

ASAP!

IL-1B is a protein released by cells under conditions of infection. Excessive release of IL-1B can be very damaging and can lead to sever disease. In a typical experiment, the typical concentration of IL-1B around stressed cells is 1000 +/- 82 pg/ml. A researcher is testing drugs that can inhibit IL-1B release. If the drugs have a z-score of -3, she will consider them promising for future study. In her experiment, stressed cells treated with drug-1 yielded 1427 pg/ml of IL-1B, while drug-2 yielded 1427 pg/ml of IL-1B. Is she going to continue studying either drug, and if so, which one?

A. She will not study drug-2 or drug-1.

B. She will continue studying drug-1 and drug-2.

C. She will continue studying drug-2 but not drug-1.

D. She will continue studying drug-1 but not drug-2.

Answer 1

Answer: The guy above was right... it is A. At least for A p e x!

Answer 2

I'm not sure but I think it is A: She will not study drug-2 or drug-1. This is because she wants less of this protein being released by the cells, but using the drug increased the level instead. Please rate low stars if this is incorrect so in the future if this turns out to be incorrect, people won't be mislead to pick the wrong answer